Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barone

Showing results (361-370 of 399) with videos related to

Pageof 40
Sort By:
British Journal of Cancer|January 25, 2007
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II studyE Bajetta, M Di Bartolomeo, R Buzzoni, et al.
Molecular and Chemical Neuropathology|January 1, 1995
Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal strokeF C Barone, L M Hillegass, M N Tzimas, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 4, 2001
Stroke genomics: approaches to identify, validate, and understand ischemic stroke gene expressionS J Read, A A Parsons, D C Harrison, et al.
Stroke|September 1, 1995
SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and miceF C Barone, P G Lysko, W J Price, et al.
Journal of Medicinal Chemistry|December 30, 2008
A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancerK P Maresca, S M Hillier, F J Femia, et al.
Clinical Genetics|January 26, 2008
Three new patients with dup(17)(p11.2p11.2) without autismD Greco, C Romano, S Reitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine aloneS Novello, P Bruzzi, C Barone, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 3, 2014
Feasibility of near-infrared spectroscopic tomography for intraoperative functional cerebral monitoring: a primate studyDaniel C Lee, Tigran Gevorgyan, Harry L Graber, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 5, 2015
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysisM Di Salvatore, L Lo Giudice, E Rossi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 30, 2010
Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trialM Rampino, U Ricardi, F Munoz, et al.
Pageof 40

Showing results (361-370 of 399) with videos related to

Sort By:
Pageof 40
British Journal of Cancer|January 25, 2007
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II studyE Bajetta, M Di Bartolomeo, R Buzzoni, et al.
Molecular and Chemical Neuropathology|January 1, 1995
Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal strokeF C Barone, L M Hillegass, M N Tzimas, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 4, 2001
Stroke genomics: approaches to identify, validate, and understand ischemic stroke gene expressionS J Read, A A Parsons, D C Harrison, et al.
Stroke|September 1, 1995
SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and miceF C Barone, P G Lysko, W J Price, et al.
Journal of Medicinal Chemistry|December 30, 2008
A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancerK P Maresca, S M Hillier, F J Femia, et al.
Clinical Genetics|January 26, 2008
Three new patients with dup(17)(p11.2p11.2) without autismD Greco, C Romano, S Reitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine aloneS Novello, P Bruzzi, C Barone, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 3, 2014
Feasibility of near-infrared spectroscopic tomography for intraoperative functional cerebral monitoring: a primate studyDaniel C Lee, Tigran Gevorgyan, Harry L Graber, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 5, 2015
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysisM Di Salvatore, L Lo Giudice, E Rossi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 30, 2010
Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trialM Rampino, U Ricardi, F Munoz, et al.
Pageof 40